Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
XOM
|
Ursula M Burns
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,500 Added 12.07% |
-
|
Jan 04
2016 |
|
XOM
|
Larry R Faulkner
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,500 Added 8.2% |
-
|
Jan 04
2016 |
|
XOM
|
Jay S Fishman
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,500 Added 9.8% |
-
|
Jan 04
2016 |
|
XOM
|
Henrietta Fore
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,500 Added 5.56% |
-
|
Jan 04
2016 |
|
XOM
|
Kenneth C Frazier
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,500 Added 8.93% |
-
|
Jan 04
2016 |
|
XOM
|
Douglas R Oberhelman
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,500 Added 19.23% |
-
|
Jan 04
2016 |
|
XOM
|
Samuel J Palmisano
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,500 Added 6.76% |
-
|
Jan 04
2016 |
|
XOM
|
Steven Reinemund
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,500 Added 5.8% |
-
|
Jan 04
2016 |
|
XOM
|
William C Weldon
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,500 Added 13.1% |
-
|
Jan 04
2016 |
|
BRK-A
|
Meryl B Witmer
Director |
BUY
Open market or private purchase
|
Direct | 600 Added 50.0% |
$77,550
$129.25 p/Share
|
Jan 04
2016 |
|
PSX
|
Berkshire Hathaway Inc
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 35,781 Added 0.06% |
$2,843,516
$79.47 p/Share
|
Jan 04
2016 |
|
PRTA
|
Arthur W Homan
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 3,125 Reduced 100.0% |
$204,719
$65.51 p/Share
|
Jan 04
2016 |
|
PRTA
|
Arthur W Homan
Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 3,125 Added 50.0% |
$69,187
$22.14 p/Share
|
Jan 04
2016 |
|
SYNH
|
Michael Gibertini |
SELL
Open market or private sale
|
Direct | 9,000 Reduced 19.88% |
$423,000
$47.0 p/Share
|
Jan 04
2016 |
|
SYNH
|
Michael Gibertini |
BUY
Exercise of conversion of derivative security
|
Direct | 9,000 Added 16.58% |
$76,050
$8.45 p/Share
|
Jan 04
2016 |
|
KWR
|
Joseph F Matrange
VP - Global Coatings |
SELL
Open market or private sale
|
Indirect | 2,000 Reduced 19.97% |
$149,380
$74.69 p/Share
|
Jan 04
2016 |
|
NCLH
|
David M. Abrams
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,155 Added 33.8% |
-
|
Jan 04
2016 |
|
NCLH
|
John Chidsey
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,879 Added 24.18% |
-
|
Jan 04
2016 |
|
NCLH
|
Russell W Galbut
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,017 Added 8.2% |
-
|
Jan 04
2016 |
|
NCLH
|
Chad A Leat
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,879 Added 30.4% |
-
|
Jan 04
2016 |
|
NCLH
|
Walter L Revell
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,155 Added 12.69% |
-
|
Jan 04
2016 |
|
NCLH
|
F Robert Salerno
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,155 Added 19.86% |
-
|
Jan 04
2016 |
|
KWR
|
Jeffry D Frisby
Director |
SELL
Bona fide gift
|
Direct | 600 Reduced 5.75% |
-
|
Jan 04
2016 |
|
INTU
|
Edward A Kangas
Director |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 100.0% |
$935,300
$93.53 p/Share
|
Jan 04
2016 |
|
INTU
|
Edward A Kangas
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 10,000 Added 50.0% |
$292,300
$29.23 p/Share
|
Jan 04
2016 |
|
CVS
|
Anne A. Finucane
Director |
SELL
Open market or private sale
|
Indirect | 2,000 Reduced 11.96% |
$191,740
$95.87 p/Share
|
Jan 04
2016 |
|
ADBE
|
Shantanu Narayen
Chair and CEO |
SELL
Open market or private sale
|
Indirect | 22,422 Reduced 3.77% |
$2,050,268
$91.44 p/Share
|
Jan 04
2016 |
|
ADBE
|
Shantanu Narayen
Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect | 22,422 Added 6.98% |
$763,021
$34.03 p/Share
|
Jan 04
2016 |
|
CMCSA
|
Kenneth J Bacon
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 5,639 Added 21.49% |
-
|
Jan 04
2016 |
|
CMCSA
|
J Michael Cook
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 9,231 Added 21.72% |
-
|
Jan 04
2016 |
|
CCK
|
John W Conway
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 33,864 Reduced 2.2% |
$1,685,073
$49.76 p/Share
|
Jan 04
2016 |
|
CCK
|
Timothy J Donahue
President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 2,384 Reduced 0.93% |
$118,628
$49.76 p/Share
|
Jan 04
2016 |
|
CCK
|
Gerard H Gifford
EVP & COO |
SELL
Payment of exercise price or tax liability
|
Direct | 1,886 Reduced 2.22% |
$93,847
$49.76 p/Share
|
Jan 04
2016 |
|
CCK
|
Thomas A Kelly
Senior Vice President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 1,347 Reduced 1.79% |
$67,027
$49.76 p/Share
|
Jan 04
2016 |
|
CCK
|
Djalma Novaes Jr
EVP & COO |
SELL
Payment of exercise price or tax liability
|
Direct | 631 Reduced 4.09% |
$31,399
$49.76 p/Share
|
Jan 04
2016 |
|
TMUS
|
Larry L Myers
EVP, Human Resources |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 2.14% |
$116,580
$38.86 p/Share
|
Jan 04
2016 |
|
CMCSA
|
Johnathan A Rodgers
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 10,161 Added 32.92% |
-
|
Jan 04
2016 |
|
SPOK
|
Nathaniel Blair Butterfield
Director |
BUY
Grant, award, or other acquisition
|
Direct | 819 Added 8.29% |
$15,004
$18.32 p/Share
|
Jan 04
2016 |
|
SPOK
|
Nicholas A Gallopo
Director |
BUY
Grant, award, or other acquisition
|
Direct | 955 Added 2.58% |
$17,496
$18.32 p/Share
|
Jan 04
2016 |
|
SPOK
|
Stacia Hylton
Director |
BUY
Grant, award, or other acquisition
|
Direct | 819 Added 36.21% |
$15,004
$18.32 p/Share
|
Jan 04
2016 |
|
SPOK
|
Brian Oreilly
Director |
BUY
Grant, award, or other acquisition
|
Direct | 819 Added 3.84% |
$15,004
$18.32 p/Share
|
Jan 04
2016 |
|
SPOK
|
Matthew Oristano
Director |
BUY
Grant, award, or other acquisition
|
Direct | 819 Added 3.78% |
$15,004
$18.32 p/Share
|
Jan 04
2016 |
|
SPOK
|
Samme L Thompson
Director |
BUY
Grant, award, or other acquisition
|
Direct | 819 Added 2.61% |
$15,004
$18.32 p/Share
|
Jan 04
2016 |
|
SPOK
|
Royce Yudkoff
Director |
BUY
Grant, award, or other acquisition
|
Direct | 819 Added 2.52% |
$15,004
$18.32 p/Share
|
Jan 04
2016 |
|
PEN
|
Daniel Donen Davis
Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 4,818 Reduced 5.77% |
$259,257
$53.81 p/Share
|
Jan 02
2016 |
|
PEN
|
Lynn Rothman
EVP and Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 4,818 Reduced 2.16% |
$259,257
$53.81 p/Share
|
Jan 02
2016 |
|
CVS
|
Helena Foulkes
EVP & President-CVS Pharmacy |
SELL
Payment of exercise price or tax liability
|
Direct | 748 Reduced 2.28% |
$72,152
$96.46 p/Share
|
Jan 02
2016 |
|
HZNP
|
Timothy P Walbert
Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 30,845 Reduced 10.73% |
$668,411
$21.67 p/Share
|
Jan 02
2016 |
|
HZNP
|
Timothy P Walbert
Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 81,675 Added 22.13% |
-
|
Jan 02
2016 |
|
HZNP
|
Jeffrey W Sherman
EVP and Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 8,576 Reduced 5.28% |
$185,842
$21.67 p/Share
|
Jan 02
2016 |